NCT07887243

Brief Summary

This study aims to evaluate the impact of a sensory-adapted dental environment (SADE) on the stress levels and behavioral responses of children with autism spectrum disorder (ASD) during dental visits. Children with ASD often experience sensory sensitivities, making traditional dental care challenging and stressful. In this study, 40 children aged 8 to 12 diagnosed with ASD, along with their parents or legal guardians, will participate in two standard dental visits spaced 30 days apart. The first visit will take place under standard clinical conditions, while the second visit will utilize a sensory-adapted dental environment featuring modified visual elements (such as dark protective glasses), auditory (noise-canceling headphones or relaxing music), taste (unflavored toothpaste), smell (sweet orange essential oil) and tactile adjustments (a weighted blanket). The study will measure stress using objective tools, including continuous digital biomarkers of stress recorded via wristbands (such as heart rate, electrodermal activity, accelerometer data, actigraphy, movement intensity, step count, metabolic equivalent of task, skin temperature, and peripheral body orientation) and the analysis of salivary lysozyme and cortisol levels in both children and parents. Additionally, standardized psychological questionnaires will be used to assess the child's sensory profile, as well as parental stress and coping strategies. The findings will help determine whether modifying the sensory environment can effectively reduce anxiety and improve the dental care experience for children with autism.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Oct 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Oct 2026Nov 2026

Study Start

First participant enrolled

October 1, 2026

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

October 7, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 21, 2026

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2026

Last Updated

October 21, 2026

Status Verified

October 1, 2026

Enrollment Period

1 month

First QC Date

October 7, 2026

Last Update Submit

October 14, 2026

Conditions

Keywords

Autism Spectrum Disorder (ASD)Sensory-Adapted Dental Environment (SADE)Pediatric DentistryDigital Biomarkers of StressSalivary LysozymeSalivary CortisolParental StressSensory ProcessingEmbracePlusEmpaticaWearable sensorsSMILED

Outcome Measures

Primary Outcomes (8)

  • Change in Child Electrodermal Activity (EDA) via Wearable Device (Empatica EmbracePlus)

    Continuous recording of skin conductance (in microSiemens, μS) via Empatica EmbracePlus to to measure child physiological stress during dental visits in RDE versus SADE conditions.

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • Change in Child Heart Rate (HR) via Wearable Device (Empatica EmbracePlus)

    Continuous recording of heart rate (in beats per minute, bpm) via Empatica EmbracePlus to measure child physiological stress during dental visits in RDE versus SADE conditions.

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • Change in Child Respiration Rate (RR) via Wearable Device (Empatica EmbracePlus)

    Continuous recording of respiratory rate (in breaths per minute, rpm) via Empatica EmbracePlus to assess child physiological stress during dental visits in RDE versus SADE conditions.

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • Change in Child Skin Temperature (ST) via Wearable Device (Empatica EmbracePlus)

    Continuous recording of skin temperature (in degrees Celsius, °C) via Empatica EmbracePlus to measure child physiological stress during dental visits in RDE versus SADE conditions.

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • Change in Child Actigraphy-Derived Physical Activity Metrics via Wearable Device (Empatica EmbracePlus)

    Continuous recording of actigraphy data derived from the tri-axial accelerometer (in gravitational force units, g) to assess child physical restlessness during dental visits in RDE versus SADE conditions.

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • Change in Child Metabolic Equivalent of Task (MET) via Wearable Device (Empatica EmbracePlus)

    Estimation of child energy expenditure measured in MET values via Empatica EmbracePlus during dental visits in RDE versus SADE conditions.

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • Change in Child Salivary Lysozyme Levels

    Quantification of salivary lysozyme concentration (in µg/mL) assessed via ELISA from saliva samples collected using the spit method immediately post-visit to measure child stress changes between RDE and SADE visits.

    Saliva samples collected immediately post-visit at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study period of approx. 30 days; samples subsequently analyzed in the laboratory.

  • Change in Child Salivary Cortisol Levels

    Quantification of salivary cortisol concentration (in nmol/L) assessed via ELISA from saliva samples collected using the spit method immediately post-visit to measure child stress changes between RDE and SADE visits.

    Saliva samples collected immediately post-visit at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study period of approx. 30 days; samples subsequently analyzed in the laboratory.

Secondary Outcomes (14)

  • Sensory Monitoring of Individual Level Experiences in Dentistry (SMILED Scale)

    Assessed at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study duration of approximately 30 days.

  • Child Sensory Profile (SSP-2)

    Assessed at baseline during Visit 1 (Day 1).

  • Child Emotional State

    Assessed immediately before and immediately after each dental visit at Visit 1 (Day 1) and Visit 2 (approx. Day 30), covering a total study period of approximately 30 days.

  • Change in Parental Electrodermal Activity (EDA) via Wearable Device (Empatica EmbracePlus)

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • Change in Paretal Heart Rate (HR) via Wearable Device (Empatica EmbracePlus)

    Measured continuously in real-time during both dental visits (Visit 1 and Visit 2), approx. 30-90 minutes per visit.

  • +9 more secondary outcomes

Study Arms (1)

SADE Intervention Group

EXPERIMENTAL

A prospective, single-arm, non-randomized interventional study where all participating complete two sequential, standardized afternoon dental visits spaced 30 days apart. Visit 1 is conducted under standard clinical conditions (Regular Dental Environment - RDE) on a clinical chair without modifications, serving as the baseline reference. Visit 2 is conducted in a single-chair operatory utilizing a Sensory-Adapted Dental Environment (SADE) featuring multi-sensory adjustments. Both visits involve dental procedures performed by the same pediatric dentist, alongside real-time physiologic stress monitoring (via Empatica EmbracePlus wristbands), salivary sample collection (lysozyme and cortisol assays), pictorial self-report mood assessments, and psychological questionnaires (custom SMILED Scale, SSP-2, PSI-IV, CISS, STAI).

Behavioral: Sensory-Adapted Dental Environment

Interventions

A multi-sensory adaptation of the dental operatory applied during the second study visit (Visit 2). The modification includes five components: visual (yellow-filtered operating lamp and dark protective glasses), auditory (noise-canceling headphones or relaxing music), tactile (a weighted blanket), olfactory (sweet orange essential oil diffusion), and gustatory (unflavored prophylaxis toothpaste). The first visit serves as the control condition using a Regular Dental Environment (RDE) without these modifications.

Also known as: SADE, Multi-sensory dental adaptation
SADE Intervention Group

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age: 8-12 years.
  • Diagnosis of Autism Spectrum Disorder (ASD): Official ASD diagnosis according to ICD-10, ICD-11, or DSM-5 criteria, confirmed by medical documentation from a psychiatrist/pediatric psychiatrist, a psychologist's opinion, or a diagnostic team.
  • No Prior Contact: No prior contact with the proposed intervention (e.g., the specific calming techniques used in the study).
  • Absence of Profound Cognitive Deficits: Required level of intellectual functioning: IQ \> 70.
  • Stable Mental and Somatic Health Status: Over the last 30 days, with no sudden health exacerbations (e.g., psychiatric episodes, hospitalizations).
  • Consent to Participate: Written informed consent obtained from the parent/legal guardian, along with the child's assent appropriate to their developmental level.
  • Role and Age: Parent or legal guardian of the minor participant diagnosed with ASD, aged over 18 years.
  • Consent to Participate: Written informed consent obtained from the parent/legal guardian as a study participant.
  • Health Status: Stable mental and somatic health status over the last 30 days.

You may not qualify if:

  • Current Anxiety Treatment: Child undergoing psychological or pharmacological therapy directly aimed at treating anxiety (e.g., CBT, anti-anxiety medications).
  • Changes in Psychotropic Medication: Initiation of a new psychotropic drug or dosage change within the 4 weeks prior to the study.
  • Diagnosis of Other Mental Disorders: Schizophrenia, schizoaffective disorders, or bipolar affective disorders that could interfere with the study.
  • Clinically Significant Suicidal Ideation: Present currently or in the recent history.
  • Persistent Aggression or Self-Aggression: Behaviors that may prevent the safe execution of the dental procedure.
  • Somatic Comorbidities Co-occurring with ASD: Conditions that may increase stress-related risks, such as pharmacologically uncontrolled epilepsy, heart failure, unstable type 1 diabetes, or central nervous system disorders.
  • Significant Family Life Instability: Within the last 4 weeks (e.g., relocation, divorce, crisis interventions).
  • Oral Pain or Salivary Disorders: Dental pain originating from the oral cavity or salivary gland secretion disorders in the child.
  • Lack of Consent: Absence of written consent from the parent/legal guardian or lack of the child's assent to participate.
  • Upper Respiratory Tract Infection: Occurring within the last 7 days.
  • Lack of Consent: Absence of written consent from the parent/legal guardian to participate as a study subject.
  • Oral Pain or Salivary Disorders: Dental pain originating from the oral cavity or salivary gland secretion disorders in the parent/legal guardian.
  • Severe Mental Function Disorders: Diagnosed severe mental impairment requiring therapy with high doses of neurotropic drugs.
  • Significant Family Life Instability: Within the last 4 weeks (e.g., relocation, divorce, crisis interventions).
  • Upper Respiratory Tract Infection: Occurring within the last 7 days. Because the study is conducted in parent-child dyads, the refusal or withdrawal of consent by one participant automatically excludes the other from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Developmental Age Dentistry, Institute of Dentistry, Jagiellonian University Medical College

Krakow, Lesser Poland Voivodeship, 31-155, Poland

Location

MeSH Terms

Conditions

Autistic DisorderAutism Spectrum Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Iwona Gregorczyk-Maga, Professor

    Department of Developmental Age Dentistry, Institute of Dentistry, Jagiellonian University Medical College

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: A prospective, single-arm, non-randomized interventional study evaluating dental-related stress in children with autism spectrum disorder (ASD) and their parents. All participants complete two subsequent study periods involving routine dental procedures: a baseline visit in a Regular Dental Environment (RDE), followed by a second visit utilizing a Sensory Adapted Dental Environment (SADE) after a 30-day interval. Child stress is measured during each procedure using objective physiological methods, alongside the evaluation of the child's sensory profile and parental stress.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lekarz dentysta

Study Record Dates

First Submitted

October 7, 2026

First Posted

October 21, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

November 13, 2026

Study Completion (Estimated)

November 13, 2026

Last Updated

October 21, 2026

Record last verified: 2026-10

Locations